Uterine Cervical Cancer: Clinical Trials

35 trials for Uterine Cervical Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 unknown, 11 completed, 5 terminated, 3 recruiting. 13 Phase 2, 7 Not applicable, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Completed 4, Terminated 3, Unknown 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Not applicable7Completed 3, Unknown 2, Enrolling by invitation 1, Recruiting 1
Phase 14Completed 3, Terminated 1
Phase 32Completed 1, Unknown 1

Follow Uterine Cervical Cancer: new trials by email Literature Review of Uterine Cervical Cancer trials Research Report on Uterine Cervical Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy
Baseline 89-Zr Pembrolizumab Immuno PET-CT, Proteomic assay, Follow-up 89-Zr Pembrolizumab Immuno PET-CT - Triple Negative Breast Cancer, Uterine Cervical Cancer
Phase 2Not yet recruitingMaria Sklodowska-Curie National Research Institute of Oncology602025-06-012025-05-16
Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
ctDNA test, Pembrolizumab - HPV-Related Carcinoma, Uterine Cervical Cancer
Phase 2RecruitingInstituto do Cancer do Estado de São Paulo1502025-03-142025-12-24
A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening
Detection of Cervical Lesions by Fluorescence Photoelectric Image - Uterine Cervical Cancer, Cervical Intraepithelial Neoplasia
Not applicableUnknownLei Li42002024-08-012024-08-15
A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection
Detection of Cervical Lesions by Fluorescence Photoelectric Image - Uterine Cervical Cancer, High Grade Squamous Intraepithelial Lesions
UnknownLei Li200002024-07-012024-07-03
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
Urine sample, 1st stream, Cervico-vaginal swab - Uterine Cervical Cancer
Not applicableRecruitingCentre Hospitalier Universitaire de Saint Etienne3502024-05-232026-05-06
Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
Cadonilimab, Nab paclitaxel - Uterine Cervical Neoplasms, Cancer of Cervix
Phase 2UnknownWomen's Hospital School Of Medicine Zhejiang University582023-06-012023-05-06
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening
Conization, Colposcopy - Uterine Cervical Cancer
Not applicableEnrolling by invitationKarolinska Institutet2802022-01-272025-03-19
Three Birds With One Stone
Screening status - Uterine Cervical Cancer, Uterine Cervix Cancer
Not applicableCompletedUniversity of Aarhus270992021-09-012023-11-18
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer
SG001 - Uterine Cervical Cancer
Phase 2UnknownCSPC ZhongQi Pharmaceutical Technology Co., Ltd.1042021-07-312021-11-22
Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
Uterine Cervical Neoplasm, Uterine Cervical Cancer
UnknownHuazhong University of Science and Technology200002021-01-012021-07-23
Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
Cisplatin+Albumin-bound paclitaxel (1 cycle) and PD-1 monoclonal antibody+Cisplatin+Albumin-bound paclitaxel (2 cycles) - Uterine Cervical Neoplasm, Uterine Cervical Cancer
Phase 2Active not recruitingHuazhong University of Science and Technology852020-12-012025-03-20
Detecting HPV DNA in Anal and Cervical Cancers
Radiation Treatment With or Without Chemotherapy, Blood Sample Collection, HPV Genotyping (HPV DNA Test) - Cervical Cancer, Anal Cancer
RecruitingUniversity of Chicago202020-10-062026-03-04
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Bosutinib, Pemetrexed - Carcinoma, Non-Small-Cell Lung, Mesothelioma
Phase 1CompletedNagla Abdel Karim62019-12-102022-06-14
A Cohort Study for the Following up of Conization
High-risk HPV, TCT - Precancerous Lesions, Conization
UnknownLei Li100002019-06-032019-06-20
DNA Methylation for Screening Uterine Cervical Lesions
DNA methylation, High-risk HPV, TCT - DNA Methylation, Uterine Cervical Cancer
UnknownLei Li3002019-06-012019-05-24
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
DNA methylation, high-risk HPV, TCT - DNA Methylation, Uterine Cervical Cancer
UnknownLei Li3002019-05-222019-05-23
Adaptative Radiotherapy for Locally Advanced Cervical Cancer
Adaptative treatment plan, External radiotherapy - Uterine Cervical Cancer
Not applicableCompletedCenter Eugene Marquis852017-04-052022-09-02
Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients
NACT, RT+PLND, Adjuvant chemotherapy - Uterine Cervical Neoplasm, Cervical Cancer
Phase 3CompletedHuazhong University of Science and Technology7742016-01-112024-10-31
Specific Molecular Signatures Predict Neoadjuvant Chemotherapy Response in Cervical Cancer
Uterine Cervical Neoplasms, Cervical Cancer
UnknownHuazhong University of Science and Technology2402016-01-012020-06-16
Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304)
Paracetamol, Ketoprofen - Uterine Cervical Cancer, Upper Aerodigestive Tract Neoplasms
Phase 2CompletedCentre Oscar Lambret682015-02-012026-03-16

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Uterine Cervical Neoplasms (35)  ·  Neoplasms (4)  ·  Squamous Intraepithelial Lesions (4)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Endometrial Neoplasms (2)  ·  Head and Neck Neoplasms (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Ovarian Neoplasms (2)  ·  Urinary Bladder Neoplasms (2)  ·  Uterine Cervical Dysplasia (2)  ·  Agnosia (1)  ·  Anal Canal Carcinoma (1)  ·  Anemia (1)  ·  Anus Neoplasms (1)  ·  Carcinoma, Renal Cell (1)

Broader conditions

Female Urogenital Diseases (35)  ·  Female Urogenital Diseases and Pregnancy Complications (35)  ·  Genital Diseases (35)  ·  Neoplasms by Site (35)  ·  Urogenital Diseases (35)  ·  Uterine Neoplasms (35)  ·  Genital Diseases, Female (34)  ·  Genital Neoplasms, Female (34)  ·  Urogenital Neoplasms (34)  ·  Uterine Cervical Diseases (34)  ·  Uterine Diseases (34)  ·  Neoplasms (31)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Male Urogenital Diseases (4)  ·  Morphological and Microscopic Findings (4)

Interventions

Cisplatin (4)  ·  Gemcitabine (3)  ·  Paclitaxel (3)  ·  Carboplatin (2)  ·  Colposcopy (2)  ·  DNA Methylation (2)  ·  Human Papillomavirus DNA Tests (2)  ·  Radiotherapy (2)  ·  ACE-011 (1)  ·  Acetaminophen (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Brachytherapy (1)  ·  Chemotherapy, Adjuvant (1)  ·  Conization (1)  ·  Drug Therapy (1)

Sponsors

Huazhong University of Science and Technology (5)  ·  Lei Li (5)  ·  Centre Oscar Lambret (2)  ·  Becton, Dickinson and Company (1)  ·  Belgian Gynaecological Oncology Group (1)  ·  CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)  ·  Center Eugene Marquis (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Chinese Academy of Medical Sciences (1)  ·  Instituto do Cancer do Estado de São Paulo (1)  ·  Karolinska Institutet (1)  ·  Maria Sklodowska-Curie National Research Institute of Oncology (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Nagla Abdel Karim (1)  ·  National Institute of Cancerología (1)

Countries

China (12)  ·  United States (7)  ·  France (4)  ·  Belgium (2)  ·  Brazil (1)  ·  Denmark (1)  ·  Finland (1)  ·  Mexico (1)  ·  Sweden (1)  ·  Thailand (1)

Top investigators

Lei Li, M.D. (3)  ·  Ding Ma, MD, PhD (2)  ·  Berit Andersen, Prof., MD, Head of Department (1)  ·  Christina Son, MD (1)  ·  Ding Ma, M.D., PhD (1)  ·  Ding Ma, MD PhD (1)  ·  Electra D Paskett, PhD (1)  ·  Ezequiel Fuentes, MD (1)  ·  Ge Lou, PHD (1)  ·  George I Gorodeski, MD PhD (1)  ·  Kristina Elfgren, MD, PhD (1)  ·  Lingying Wu, Medical PhD (1)

Results publications

PMID 25802932, PMID 26370220, PMID 26869597, PMID 29247086, PMID 31074236, PMID 36137619, PMID 36471257, PMID 37253491, PMID 37985817, PMID 38048802, PMID 39137185, PMID 39447517

NIH funding

2005 (1), P50CA105632 (1)